Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 78 of 102, showing 5 Applications out of 507 total, starting on record 386, ending on 390

# Protocol No Study Title Investigator(s) & Site(s)

386.

ECCT/13/08/02   MalPaC Trial
    Comparing drug-regimens for clearing parasites in Phase IIb trial designs prior to PCR monitoring for Plasmodium falciparum infection.   
Principal Investigator(s)
1. Caroline Amolo Ogwang
2. Francis Maina Ndung\'u
Site(s) in Kenya
Junju
 
View

387.

ECCT/24/03/03   DoxyDOT Study
    Weekly doxycycline DOT for STI prevention among cisgender women taking HIV PrEP in Kisumu, Kenya   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
KEMRI CMR RCTP
 
View

388.

ECCT/21/08/01   CARES
    Phase 3b, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy, Safety,and Tolerability of Switching to Long-Acting Cabotegravir Plus Long-Acting Rilpivirine From Current Antiretroviral Regimen in HIV-1 Infected, Virologically Suppressed Adults in Sub-Saharan Africa.   
Principal Investigator(s)
1. JOSPHAT KOSGEI
Site(s) in Kenya
1. AMPATH Eldoret (Uasin Gishu county)
2. Aghakhan University (Nairobi City county)
3. Kericho KEMRI WRP CRC site (Kericho county)
 
View

389.

ECCT/13/05/02  
    An open-label randomized controlled trial of the efficacy and safety of Clindamycin plus quinine compared with artemether-lumefantrine for the treatment of children with uncomplicated  falciparum malaria in western Kenya   
Principal Investigator(s)
1. CHARLES OWUORA OBONYO
Site(s) in Kenya
Ahero Sub-district Hospital
 
View

390.

ECCT/22/08/04   Protocol H06_01TP
    A staged Phase I/II observer-blind, randomised, controlled, multi-country study to evaluate the safety, reactogenicity, and immune responses to the GVGH altSonflex1-2-3 vaccine against S. sonnei and S. flexneri, serotypes 1b, 2a, and 3a, in adults in Europe (Stage 1) followed by age de-escalation from adults to children and infants, and dose-finding in infants in Africa (Stage 2)           
Principal Investigator(s)
1. Deborah Chepngeno Langat Langat
Site(s) in Kenya
KEMRI WRP CRC KERICHO
 
View